Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:36:01 EDT Sun 25 Oct 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 23 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-10-25 12:00U:ORKANews ReleaseOruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-B Trial on October 26, 2026
2026-10-25 11:52U:SMMTNews ReleaseIvonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 Study Conducted by Akeso in China
2026-10-25 11:35U:AZNNews ReleaseSonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
2026-10-25 11:30U:RHHBYNews ReleaseGenentech's Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer
2026-10-25 11:30U:AZNNews ReleaseTAGRISSO(TM) (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
2026-10-25 09:45U:JNJNews ReleaseRYBREVANT FASPRO(TM) (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer
2026-10-25 09:00U:AVBPNews ReleaseArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
2026-10-25 08:11U:AMRNNews ReleaseAmarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA(TM)/VASCEPA(TM) (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Patients Undergoing Liver Resection for Colorectal Canc
2026-10-25 07:00U:NBPNews ReleaseNovaBridge Biosciences Reports Mature Phase 1b Data at ESMO 2026 Positioning Givastomig for Registrational Development
2026-10-25 07:00U:GMABNews ReleaseGenmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
2026-10-25 07:00U:AGENNews ReleaseAgenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
2026-10-25 06:22U:BORRNews ReleaseBorr Drilling Limited - Prospector 5 Rig Incident
2026-10-25 05:15U:REGNNews ReleaseLibtayo(TM) (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)
2026-10-25 04:35U:XNCRNews ReleaseXencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumors
2026-10-25 03:30U:LLYNews ReleaseNew data on Lilly's investigational treatment olomorasib at ESMO 2026 show durable first-line activity in KRAS G12C-mutant non-small cell lung cancer
2026-10-25 03:30U:JNJNews ReleaseJohnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC(TM) molecule
2026-10-25 03:30U:BNTXNews ReleaseBioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy
2026-10-24 23:57U:GXRFFNews ReleaseProspera Energy Announces Service Rig Update as Luseland Workovers Come Online at 3.3x Prior Rates
2026-10-24 20:00U:ELEKNews ReleaseFrom Record-High Market Excitement to American Lithium Ambition: Elektros Looks North
2026-10-24 19:30U:ELEKNews ReleaseWall Street Fever, an Early Christmas in October: Penny Stock Lovers, This Is Your Time To Shine
2026-10-24 19:30U:CLYMNews ReleaseClimb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026
2026-10-24 16:06U:GGIINews ReleaseSiren's Tale Vodka to Exhibit at SoCal Cocktail and Spirits Fest
2026-10-24 15:19U:TECKNews ReleaseTeck Provides Update on Highland Valley Copper Operations